About ceres pharma
Innovation in healthcare & wellbeing
Ceres Pharma was founded in the summer of 2017 as an umbrella company housing four existing companies: Pharco Innovations, Etixx Sports, Primrose Pharma and Calxx Laboratories. Active in the sector of over-the-counter (OTC) products, the company is owned by investors Marc Coucke and CEO Mario Debel, and intends to grow by developing its own portfolio and through acquisitions.
In August 2018, Ceres Pharma enlarged its product range by taken over the complete medicines portfolio of Mithra for BeLux (in the categories contraception, menopause, urology and HPV infections).
Your good health is our prime concern. That is why we specialise in the development, production and distribution of drugs, medical products and high-quality food supplements. The high-quality food supplements are based on the latest scientific insights in the field of nutritherapy and phytotherapy.
In our search for innovative products, we see ourselves as a trustworthy and reliable partner pursuing a targeted approach in line with our core values.
A multidisciplinary team composed of physicians, pharmacists and in-house researchers, develops products based on the latest scientific insights in the field of nutritherapy and phytotherapy. The focus is on making a significant contribution to health and wellness.
STRICT PRODUCTION PROCESSES AND HIGH QUALITY DEMANDS
Every step in the development process is subjected to stringent procedures to prevent errors and deliver a reliable product. GMP (Good Manufacturing Practice) is deeply ingrained in our standard production process, ensuring the products we deliver can be used safely.
We work to the highest possible standards. In-depth clinical studies with our products provide evidence of their efficacy and therapeutic safety (no side effects).
In doing so, our experience in developing and selling medical testing kits and high-tech food supplements guarantees unanimously positive results.